Somerville, MA, United States of America

Kimberly Hamad-Schifferli

USPTO Granted Patents = 6 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kimberly Hamad-Schifferli: Innovator in Dengue Virus Detection

Introduction

Kimberly Hamad-Schifferli is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of biomedical research, particularly in the detection and treatment of dengue virus infections. With a total of 6 patents to her name, her work has the potential to impact public health positively.

Latest Patents

One of her latest patents focuses on the development of anti-dengue virus NS1 protein monoclonal antibodies. This invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in biological samples. Each matched antibody pair is designed to detect only one serotype of dengue virus NS1 protein, ensuring specificity and reducing cross-reactivity with other serotypes. The invention facilitates the creation of confirmatory in vitro diagnostic tests, such as sandwich immunoassays, which can distinguish the presence of dengue virus serotypes in samples derived from human subjects. Additionally, the invention includes kits comprising these matched antibody pairs and methods for their use in immunoassays. The therapeutic compositions and methods for treating dengue virus infection further enhance the significance of her work.

Career Highlights

Hamad-Schifferli has worked with esteemed institutions, including the Massachusetts Institute of Technology and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these organizations has contributed to her expertise in the field of biomedical research.

Collaborations

Some of her notable coworkers include Irene Bosch and Lee Gehrke, who have collaborated with her on various research projects.

Conclusion

Kimberly Hamad-Schifferli's innovative work in the detection and treatment of dengue virus infections showcases her dedication to advancing biomedical research. Her contributions have the potential to improve diagnostic methods and therapeutic options for dengue virus, ultimately benefiting public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…